Skip to Main Content

Paper Details

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Sci Rep
34
2018
Breast Cancer, Breast cancer, CDH1, E, E-cadherin, ER, ER-positive, ER-positive tumors, HER2, breast, breast cancer, breast tumor, estrogen, estrogen receptor, histologic, histologic subtype, invasive breast cancers, putative tumor suppressor gene, tumor, tumor subtypes
Author NameAffiliation
Hisani N HorneNational Cancer Institute
Hisani N Horne
Hisani N HorneNational Cancer Institute
Hisani N Horne
Mark E ShermanMayo Clinic
Mark E ShermanMayo Clinic
Stephen M HewittCenter for Cancer Research, National Cancer Institute
Stephen M HewittCenter for Cancer Research, National Cancer Institute
Roger L Milne
Roger L MilneThe University of Melbourne
Javier Ben??tezSpanish National Cancer Research Centre
Javier Ben??tez
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
John W M MartensFamily Cancer Clinic, Erasmus MC Cancer Institute
Janet E OlsonMayo Clinic
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Kathryn J RuddyMayo Clinic
Caroline SeynaeveFamily Cancer Clinic, Erasmus MC Cancer Institute
Melissa A TroesterLineberger Comprehensive Cancer Center, University of North Carolina
Christi J van AsperenLeiden University Medical Center
Carolien H M van DeurzenErasmus University Medical Center
Laura J Van't VeerThe Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Montserrat Garcia-ClosasNational Cancer Institute
Montserrat Garcia-ClosasNational Cancer Institute
Jonine D FigueroaNational Cancer Institute
Jonine D FigueroaThe University of Edinburgh Medical School
Jonine D FigueroaNational Cancer Institute
Jonine D FigueroaThe University of Edinburgh Medical School
  • 1 - 36

Datasets

Release 1.2